Abu Dhabi-based investment and holding company ADQ, and E20 Investment, an agribusiness investment company in the UAE, have entered into an agreement to establish a new animal health platform in Abu Dhabi.
The animal health platform will initially comprise a cutting-edge animal vaccine manufacturing facility and a complex with two state-of-the-art animal hospitals. Once operational, the facilities will further enhance Abu Dhabi’s position as a regional leader in high-end veterinary services for horses and camels while producing the most technologically advanced animal vaccines serving the Middle East and Africa (MEA) region.
Fahad Al Qassim, Executive Director, Healthcare & Life Sciences Portfolio at ADQ, said: “Leveraging our healthcare and life sciences expertise, we have identified an opportunity to create an adjacent platform in animal health. By creating a joint venture with E20, we will capitalize on Abu Dhabi’s strong market potential for animal vaccine production and maintaining the health and welfare of prized animals, such as horses and camels.”